 last several decades, understanding genetic variation, pathophysiology, complications hemolytic anemia associated red cell pyruvate kinase deficiency (PKD) expanded. Nonetheless, remain significant gaps knowledge regard clinical care monitoring. Treatment remains supportive phototherapy and/or exchange transfusion newborn period, regular intermittent red cell transfusions children adults, splenectomy decrease transfusion requirements and/or anemia related symptoms. article, review clinical diversity PKD, current standard treatment supportive care, complications observed, future treatment directions.